Sustained-Release Dual-Drug Ternary Salt Cocrystal of Piperazine Ferulate with Pyrazinamide: Synthesis, Structure, and Hirshfeld Surface Analysis

A novel dual-drug ternary salt cocrystal of piperazine ferulate (PRZ–FLA) with pyrazinamide (PRA), namely, PRZ–FLA–PRA, has been synthesized and characterized. Single-crystal X-ray diffraction reve...

• Publication year

  2020

• Venue

  Crystal Growth & Design

• Publication date

  2020-01-28

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1021/acs.cgd.9b01710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The comparative study of cocrystal/salt in simultaneously improving solubility and permeability of acetazolamide

  2019cited by this paper
• Luteolin cocrystals: Characterization, evaluation of solubility, oral bioavailability and theoretical calculation

  2019cited by this paper
• Pharmaceutical cocrystals: from serendipity to design to application.

  2019cited by this paper
• Cocrystal of Apigenin with Higher Solubility, Enhanced Oral Bioavailability, and Anti-inflammatory Effect

  2019cited by this paper
• Pharmaceutical Cocrystal Drug Products: An Outlook on Product Development.

  2018cited by this paper
• Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy.

  2018cited by this paper
• Protective Effects of Quercetin against Pyrazinamide Induced Hepatotoxicity via a Cocrystallization Strategy of Complementary Advantages

  2018cited by this paper
• Unraveling the Hydrogen Bond Network in a Theophylline–Pyridoxine Salt Cocrystal by a Combined X-ray Diffraction, Solid-State NMR, and Computational Approach

  2018cited by this paper
• Drug-Bridge-Drug Ternary Cocrystallization Strategy for Antituberculosis Drugs Combination

  2018cited by this paper
• Co-crystal of Tramadol Hydrochloride–Celecoxib (ctc): A Novel API–API Co-crystal for the Treatment of Pain

  2017cited by this paper
• New solid state forms of antineoplastic 5-fluorouracil with anthelmintic piperazine

  2017cited by this paper
• Modulating the Dissolution and Mechanical Properties of Resveratrol by Cocrystallization

  2017cited by this paper
• Early Diagnosis of Tuberculosis-Associated IgA Nephropathy with ESAT-6.

  2017cited by this paper
• Tuberculosis and chronic kidney disease: an emerging global syndemic.

  2016cited by this paper
• Influence of pretreatment of piperazine ferulate on pharmacokinetic parameters of methotrexate in methotrexate-induced renal injury model rats by HPLC-MS

  2016cited by this paper
• Cocrystal and Salt Forms of Furosemide: Solubility and Diffusion Variations

  2016cited by this paper
• Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.

  2016cited by this paper
• A Drug-Drug Salt Hydrate of Norfloxacin and Sulfathiazole: Enhancement of in Vitro Biological Properties via Improved Physicochemical Properties.

  2016cited by this paper
• Multidrug co-crystals: towards the development of effective therapeutic hybrids.

  2016cited by this paper
• Genitourinary tuberculosis in North America: A rare clinical entity.

  2015cited by this paper
• Drug-Drug Molecular Salt Hydrate of an Anticancer Drug Gefitinib and a Loop Diuretic Drug Furosemide: An Alternative for Multidrug Treatment.

  2015cited by this paper
• Cocrystals of the Tuberculosis Drug Isoniazid: Polymorphism, Isostructurality, and Stability

  2014cited by this paper
• Pharmaceutical Co-Crystals of Pyrazinecarboxamide (PZA) with Various Carboxylic Acids: Crystallography, Hirshfeld Surfaces, and Dissolution Study

  2013cited by this paper
• General acteoside of Rehmanniae leaves in the treatment of primary chronic glomerulonephritis: a randomized controlled trial.

  2013cited by this paper
• Molecules in crystals

  2013cited by this paper
• Novel furosemide cocrystals and selection of high solubility drug forms.

  2012cited by this paper
• Improving the Solubility of 6-Mercaptopurine via Cocrystals and Salts

  2012cited by this paper
• Co-crystals of caffeine and piracetam with 4-hydroxybenzoic acid: Unravelling the hidden hydrates of 1 : 1 co-crystals

  2012cited by this paper
• Unintended water mediated cocrystal formation in carbamazepine and aspirin tablets.

  2011cited by this paper
• Pharmaceutical cocrystals: an overview.

  2011cited by this paper
• Vibrational Spectroscopic Studies of Cocrystals and Salts. 3. Cocrystal Products Formed by Benzenecarboxylic Acids and Their Sodium Salts

  2010cited by this paper
• Synthesis and preliminary characterization of sulfamethazine-theophylline co-crystal.

  2010cited by this paper
• Bioavailability of indomethacin‐saccharin cocrystals

  2010cited by this paper
• Solubility Advantage of Pharmaceutical Cocrystals

  2009cited by this paper
• Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients

  2008cited by this paper
• Cocrystal architecture and properties: design and building of chiral and racemic structures by solid-solid reactions.

  2007cited by this paper
• Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces.

  2007cited by this paper
• A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.

  2006cited by this paper
• Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation

  2006cited by this paper
• Adverse reactions to first-line antituberculosis drugs

  2006cited by this paper
• Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities.

  2005cited by this paper
• Crystal and molecular structure of acetazolamide (5-acetamido-1,3,4-thiadiazole-2-sulphonamide), a potent inhibitor of carbonic anhydrase

  1974cited by this paper

• Phenforminium fenbufenate as the first dual-drug molecular salt of phenformin with NSAIDs towards tuning dissolution behavior and enhancing synergic anticancer activity in vitro

  2025cites this paper
• Preparation, advanced characterization, and current regulatory roadmap for pharmaceutical cocrystals

  2025cites this paper
• Selection of Chrysin cocrystals or hydrated salt to enhance its poor dissolution property

  2025cites this paper
• Advances in solvent based cocrystallization: Bridging the gap between theory and practice

  2024cites this paper
• "Unveiling the Anticancer Potential: Exploring 4-Fluoro Benzoic Acid and Piperazine through Spectroscopic, X-ray Diffraction, DFT and Molecular Docking Analysis"

  2024cites this paper
• Organic Crystals: Comprehensive Understanding of Proton States of Naftopidil Salts via XPS

  2024cites this paper
• An analysis of multidrug multicomponent crystals as tools for drug development.

  2024cites this paper
• Molecular complexes of drug combinations: a review of cocrystals, salts, coamorphous systems and amorphous solid dispersions.

  2023cites this paper
• Molecular Structures of Eight Hydrogen Bond-mediated Minoxidil Adducts From Different Aryl Acids

  2023cites this paper
• Multicomponent Crystals of Amitriptyline as Potential Controlled-Release Systems: Synthesis, Crystal Packing Analysis, and Dissolution Study

  2023cites this paper
• 2D-3D Supramolecular Assemblies Containing 2-amino-4,6-dimethoxypyrimidine and Carboxylic Acids: Preparation, Crystallographic Characterization, and Hirshfeld Surface Analysis

  2023cites this paper
• Molecular Structure Analysis of the Chlorhexidine Salts

  2023cites this paper
• Cocrystal and Coamorphous Solid Forms of Enzalutamide with Saccharin: Structural Characterization and Dissolution Studies

  2022cites this paper
• Investigating the Role of the Reduced Solubility of the Pirfenidone-Fumaric Acid Cocrystal in Sustaining the Release Rate from Its Tablet Dosage Form by Conducting Comparative Bioavailability Study in Healthy Human Volunteers.

  2022cites this paper
• Pyrazinamide–isoniazid hybrid: synthesis optimisation, characterisation, and antituberculous activity

  2022cites this paper
• A novel cocrystal of metformin hydrochloride with citric acid: Systematic synthesis and computational simulation.

  2022cites this paper
• “Drug–Coformer–Drug” Multicomponent Crystals to Simultaneously Improve the Solubility of Two Insoluble Combined Drugs by Introduction of a Soluble Coformer

  2022cites this paper
• Melt Crystallization of Celecoxib-Carbamazepine Cocrystals with the Synchronized Release of Drugs

  2022cites this paper
• Single crystal X-ray structural and Hirshfeld surface analysis dataset for some isobutyl-1,2,6-triaryl-4-(arylamino)-1,2,5,6-tetrahydropyridine-3-carboxylates

  2021cites this paper
• Improving the Physicochemical and Biopharmaceutical Properties of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicine through Cocrystal Engineering

  2021influential citation
• Molecular Structures of Ten Ionic Hydrogen Bond-mediated Anhydrous tert-butylammonium Salts From Different Carboxylic Acids

  2021cites this paper
• Cocrystal engineering of pharmaceutical solids: therapeutic potential and challenges

  2021cites this paper
• Amino Acids as the Potential Co-Former for Co-Crystal Development: A Review

  2021cites this paper
• Cocrystals of Propylthiouracil and Nutraceuticals toward Sustained-Release: Design, Structure Analysis, and Solid-State Characterization

  2021cites this paper
• Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications

  2021cites this paper
• Similar but Not the Same: Difference in the Ability to Form Cocrystals between Nimesulide and the Pyridine Analogues

  2020cites this paper
• Cocrystallization: cutting edge tool for physicochemical modulation of active pharmaceutical ingredients.

  2020cites this paper